Related Experiment Video

Updated: Aug 9, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

IkappaB kinase signaling is essential for maintenance of mature B cells

Manolis Pasparakis1, Marc Schmidt-Supprian, Klaus Rajewsky

  • 1Institute for Genetics, University of Cologne, D-50931 Cologne, Germany.

The Journal of Experimental Medicine
|September 18, 2002
PubMed

Insights

Nuclear factor-kappaB (NF-κB) signaling is vital for immune cells. This study shows that inhibiting NF-κB signaling in B cells leads to their loss, highlighting its role in B cell maintenance.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Nuclear factor-kappaB (NF-κB) proteins are critical regulators of immune responses and cell survival.
  • NF-κB activation is controlled by the IkappaB kinase (IKK) complex, comprising IKK1, IKK2, and the regulatory subunit NF-kappaB essential modulator (NEMO).
  • IKK2 and NEMO deficiency result in embryonic lethality, necessitating conditional gene targeting for studying their roles in adult tissues.

Purpose of the Study:

  • To investigate the function of IKK signaling and IKK2 in the development and maintenance of mature B lymphocytes in adult mice.
  • To elucidate the specific roles of NEMO and IKK2 in B cell survival through conditional gene targeting.

Main Methods:

  • Conditional gene targeting in mice to specifically delete NEMO or ablate IKK2 activity in B cells.
  • Analysis of B cell populations in adult mice following targeted gene disruption.

Main Results:

  • B lineage-specific deletion of NEMO resulted in the complete loss of mature B lymphocytes.
  • Ablation of IKK2 activity in a B lineage-specific manner also led to the disappearance of mature B cells.
  • These findings indicate a critical dependence of mature B cells on IKK-mediated NF-κB activation.

Conclusions:

  • The maintenance of mature B lymphocytes is dependent on IKK-mediated activation of the NF-κB signaling pathway.
  • IKK signaling, specifically through NEMO and IKK2, is essential for the survival of mature B cells.
  • Targeting IKK signaling in B cells offers potential insights into immune system regulation and related pathologies.

More Related Videos

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...